TNI argues in favour of prioritising the participation of small farmers to advance sustainable and equitable markets.

Frontline AIDS explains the need to shift focus from criminalising drugs to adequately equipping a health-orientated response.

INPUD interrogates 'progress' toward decriminalisation, pointing to gaps and pending challenges, including in relation to enduring stigmatisation and prohibition.

IDPC provides a critique of the UNODC Strategy 2021-2025 with a focus on two critical issues: the exclusion of civil society and communities from the development and approval of the document; and the departure from the policy priorities established in the 2018 UN system Common Position on drugs.

IDPC takes stock of progress made on the implementation of the recommendations included in the UNGASS Outcome Document, focusing on six critical areas: public health, development, human rights, civil society engagement, UN agency collaboration and cooperation, and drug policy evaluation.

ITPC and Dristi Nepal offer insights into the challenges posed by the COVID-19 pandemic on populations impacted by HIV, and responses by civil society and community networks.

FCAA highlights how marginalised communities in the US and globally have been impacted by COVID-19 and how their needs have changed over the past year.

EHRA assesses harm reduction and law enforcement responses to new psychoactive substances in Estonia.

INHSU outlines challenges and opportunities in harm reduction responses during the COVID-19 pandemic.

IDPC and TNI provide an overview of the evolution of the UN-agreed language on key drug policy issues for the last three decades.

Despite a historic fall in the number of people executed for drug offences worldwide, the amount of people sentenced to death has worryingly increased.

APCOF sheds lights on the impact of securitised responses to the COVID-19 pandemic on marginalised populations.

C-EHRN shared data on the experiences of harm reduction service providers and service users in the region.

The new UNAIDS strategy introduces important and ambitious goals to remove policies that fuel the criminalisation of key populations, including people who use drugs.

The DLA outlines initiatives to protect the health and safety of people in custodial settings in the context of the pandemic situation, as well as their limitations.

Informed by international case studies, the Scottish government highlights the role of criminalisation in exacerbating harm and undermining health responses, acknowledging the need for a sweeping policy overhaul.

The INCB's annual report reflects both progress and shortcomings in the Board's approach to drug control, further integrating human rights considerations whilst showing a degree of inflexibility in relation to national criminal justice reforms.

APCOM explores motivations, impacts and responses to address health concerns

Chang et al. highlight the benefits and shortcomings of existing initiatives involving peers in the delivery of HIV and harm reduction programming.

The EMCDDA describes the main effects of COVID-19-related restrictions on the drug using population and on the provision and demand for drug services, and their gradual adaptation to the changing situation in countries from the Western Balkan region.